Figures computed from official regulatory filings — .
Ownershipinsiders 36.44% · institutions 26.79%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for AELIS FARMA only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company owns a pipeline of pharmacological inhibitors, including AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; AEF0217, a drug candidate, which is in phase 1/2 clinical trials to treat cognitive deficits observed in down syndrome; and CB1-SSi, a new molecular entities to treat other CB1-dependent diseases, including several orphan diseases. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
11 buys1 sell— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Pier Vincenzo Piazzatrack record | Buy | $3K | conv 49 |
| AMF |
| Pier Vincenzo Piazzatrack record | Buy | $307.1 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $153.1 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $611.9 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $229 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $154.5 | conv 21 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $688.6 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $303.8 | conv 20 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $302.9 | conv 36 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $756.8 | conv 31 | AMF |
| Pier Vincenzo Piazzatrack record | Buy | $3.5K | conv 51First in 12mo | AMF |
| Pier Vincenzo Piazzatrack record | Sell | $159K | AMF |